Fig. 2From: The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degenerationOCTA imaging of a pure type 3 MNV. a–c Baseline OCTA imaging from the RTVue XR Avanti device. a En face OCTA image of projection between the RPE and Bruch’s membrane segmentation lines depicting the MNV vessels (yellow arrow). b Corresponding B-scan through the lesion showing flow signal anterior to the RPE (yellow arrow). c Corresponding B-scan through the lesion showing the segmentation lines. d–f Endpoint OCTA imaging from the Cirrus HD-OCT 5000 device 21 months after the baseline imaging and after 11 total intravitreal injections of anti-VEGF. d En face OCTA image of the outer retina slab showing the MNV flow (yellow arrow). e Corresponding B-scan through the lesion with flow signal (yellow arrow). f Corresponding B-scan through the lesion showing segmentation lines for the outer retinaBack to article page